Published in PLoS One on March 12, 2014
COPD: balancing oxidants and antioxidants. Int J Chron Obstruct Pulmon Dis (2015) 1.03
Dual-Directional Immunomodulatory Effects of Corbrin Capsule on Autoimmune Thyroid Diseases. Evid Based Complement Alternat Med (2016) 0.75
The inhibitory mechanism of Cordyceps sinensis on cigarette smoke extract-induced senescence in human bronchial epithelial cells. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease--A Randomized Placebo Controlled Double Blind Clinical Trial. PLoS One (2015) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
Health status measurement in chronic obstructive pulmonary disease. Thorax (2001) 3.07
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
ABC of complementary medicine: herbal medicine. BMJ (1999) 2.26
Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J (2005) 2.23
Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J (2007) 2.04
A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun (2004) 1.99
Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.88
Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2010) 1.83
Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Devel (2010) 1.73
Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD (2005) 1.68
A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest (2005) 1.66
The BODE index after lung volume reduction surgery correlates with survival. Chest (2006) 1.66
Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol (2006) 1.51
Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med (2012) 1.35
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res (2010) 1.31
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc (2011) 1.28
Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust (2004) 1.20
Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respir Med (2010) 1.18
Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum bark extracts. J Ethnopharmacol (2007) 1.07
Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD. Respir Res (2012) 1.07
Cordyceps sinensis as an immunomodulatory agent. Am J Chin Med (1996) 1.03
Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals. PLoS One (2010) 1.03
Panax ginseng in randomised controlled trials: a systematic review. Phytother Res (2012) 1.00
Oral Chinese herbal medicine for improvement of quality of life in patients with stable chronic obstructive pulmonary disease: a systematic review. J Altern Complement Med (2012) 0.99
BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci (2010) 0.98
Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sci (2001) 0.95
Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test. COPD (2007) 0.94
Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J Ethnopharmacol (2008) 0.94
Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med (2011) 0.93
Cochrane systematic reviews of Chinese herbal medicines: an overview. PLoS One (2011) 0.92
Cordyceps sinensis promotes exercise endurance capacity of rats by activating skeletal muscle metabolic regulators. J Ethnopharmacol (2011) 0.91
An extract of Crataegus pinnatifida fruit attenuates airway inflammation by modulation of matrix metalloproteinase-9 in ovalbumin induced asthma. PLoS One (2012) 0.86
Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem (2002) 0.85
Down-regulation of apoptotic and inflammatory genes by Cordyceps sinensis extract in rat kidney following ischemia/reperfusion. Transplant Proc (2001) 0.82
[Intervention effect of tongfei mixture on nocturnal hypoxia in patients with chronic obstructive pulmonary disease]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2004) 0.81
Gene expression profiling of dendritic cells in different physiological stages under Cordyceps sinensis treatment. PLoS One (2012) 0.81
The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients. Clin Respir J (2010) 0.80
The effects of Chinese yam-epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease. J Tradit Chin Med (2012) 0.77
[Therapy for clearing heat and resolving phlegm in treatment of systemic inflammatory response syndrome in acute deterioration stage of chronic obstructive pulmonary disease: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao (2009) 0.76
[Study on mechanism of traditional Chinese medicines reducing phlegm and resolving masses in treatment of goiter]. Zhongguo Zhong Yao Za Zhi (2012) 0.76